David Migneault

This inventor holds 15 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Amyloid Disease Treatments. Top assignees: Neurochem (International) Limited, Bellus Health Inc., Bhi Limited Partnership. Active years: 2003-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Migneault. Retrieved from https://idiyas.com/inventor/david-migneault

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 40.0

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 151(Granted Patents)

Company Filing History:

5 out of 9

Neurochem (International) Limited

Bhi Limited Partnership

patents

4. 1 out of 3

Bellus Health (International) Limited

patents

5. 1 out of 425

Queen's University at Kingston

patents

Years Active: 2003-2021

Loading Chart...

Areas of Expertise:

3-Amino-1-Propanesulfonic Acid

Amyloid-Related Diseases

Inhibiting Amyloid Deposits

Pharmaceutical Drug Candidates

Compositions

Delivery Methods

Imaging Agents

Amidine Derivatives

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11020360 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2021-06-01),

2. 10857109 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2020-12-08),

3. 10238611 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2019-03-26),

4. 9499480 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2016-11-22),

5. 8835654 - Method and compositions for treating amyloid-related diseases (2014-09-16),

6. 8748656 - Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (2014-06-10),

7. 8642801 - Methods and compositions for treating amyloid-related diseases (2014-02-04),

8. 8044100 - Methods and compositions for treating amyloid-related diseases (2011-10-25),

9. 7786174 - Methods and compounds for inhibiting amyloid deposits (2010-08-31),

10. 7414076 - Methods and compositions for treating amyloid-related diseases (2008-08-19),

11. 7393875 - Methods and compounds for inhibiting amyloid deposits (2008-07-01),

12. 7311893 - Amyloid targeting imaging agents and uses thereof (2007-12-25),

13. 7262223 - Amidine derivatives for treating amyloidosis (2007-08-28),

14. 7253306 - Pharmaceutical drug candidates and methods for preparation thereof (2007-08-07),

15. 6562836 - Methods and compounds for inhibiting amyloid deposits (2003-05-13),

Title: David Migneault - Innovative Inventor from Laval, CA

Introduction: David Migneault is a talented inventor hailing from Laval, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: David Migneault holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his diverse range of expertise and forward-thinking approach.

Career Highlights: With a career spanning over two decades, David Migneault has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, David Migneault has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products and technologies that have made a significant impact on society.

Conclusion: David Migneault's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, solidifies his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.